Macrogenics Inc (MGNX)
4.37
-0.75
(-14.65%)
USD |
NASDAQ |
May 17, 16:00
4.42
+0.05
(+1.14%)
After-Hours: 20:00
Macrogenics Cash from Operations (TTM): -111.02M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -111.02M |
December 31, 2023 | -78.20M |
September 30, 2023 | -20.85M |
June 30, 2023 | 4.976M |
March 31, 2023 | -42.10M |
December 31, 2022 | -86.96M |
September 30, 2022 | -170.59M |
June 30, 2022 | -175.96M |
March 31, 2022 | -172.49M |
December 31, 2021 | -143.83M |
September 30, 2021 | -95.05M |
June 30, 2021 | -105.94M |
March 31, 2021 | -96.79M |
December 31, 2020 | -111.90M |
September 30, 2020 | -144.41M |
June 30, 2020 | -136.12M |
March 31, 2020 | -148.41M |
December 31, 2019 | -134.27M |
September 30, 2019 | -123.45M |
June 30, 2019 | -143.05M |
March 31, 2019 | -151.94M |
Date | Value |
---|---|
December 31, 2018 | -153.23M |
September 30, 2018 | -14.16M |
June 30, 2018 | -8.535M |
March 31, 2018 | 18.44M |
December 31, 2017 | 14.40M |
September 30, 2017 | -125.77M |
June 30, 2017 | -44.63M |
March 31, 2017 | -47.10M |
December 31, 2016 | -43.68M |
September 30, 2016 | -39.50M |
June 30, 2016 | -96.92M |
March 31, 2016 | -89.16M |
December 31, 2015 | -13.66M |
September 30, 2015 | -9.67M |
June 30, 2015 | -16.37M |
March 31, 2015 | 4.948M |
December 31, 2014 | -32.76M |
September 30, 2014 | -13.78M |
June 30, 2014 | 1.359M |
March 31, 2014 | -4.437M |
December 31, 2013 | -14.17M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-175.96M
Minimum
Jun 2022
4.976M
Maximum
Jun 2023
-111.82M
Average
-117.68M
Median
Cash from Operations (TTM) Benchmarks
Moderna Inc | -2.882B |
Allurion Technologies Inc | -62.30M |
Novavax Inc | -471.93M |
United Therapeutics Corp | 979.70M |
MEI Pharma Inc | -43.78M |